Northeast Pharmaceuticals Group
Northeast Pharmaceuticals Group, commonly referred to as NE Pharm, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence across Asia and expanding into global markets, Northeast Pharmaceuticals is recognised for its commitment to quality and innovation. The company’s core offerings, which include generic and specialty medications, are distinguished by their adherence to stringent regulatory standards and a focus on research and development. Northeast Pharmaceuticals has achieved notable milestones, positioning itself as a trusted supplier in the pharmaceutical sector, and continues to enhance its market presence through strategic partnerships and a robust product pipeline.
DitchCarbon Score
How does Northeast Pharmaceuticals Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Northeast Pharmaceuticals Group's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Northeast Pharmaceuticals Group's reported carbon emissions
Northeast Pharmaceuticals Group, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Northeast Pharmaceuticals Group may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed their initiatives. As the pharmaceutical industry increasingly prioritises sustainability and climate action, it is essential for companies like Northeast Pharmaceuticals Group to establish clear emissions reduction goals and commitments to align with global climate standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Northeast Pharmaceuticals Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
